Photo from Petros Grivas/X
Jan 5, 2024, 11:46
Petros Grivas: This is a product of teamwork for many years
Petros Grivas, Associate Professor at University of Washington, shared on X/Twitter:
“This is a product of teamwork for many years: investigator-initiated trial of nivolumab +/- lirilumab as neoadjuvant treatment in cisplatin-ineligible patients with MIBC! Vadim Koshkin was a fellow when we started!”
Visit the article website.
Source: Petros Grivas/X
Jul 27, 2024, 11:24